Euro Results Round-Up: Alliance Pharma, Boiron And Ipsen
Round-up of Q2 and H1 financial results from three Europe-based consumer health companies: Alliance Pharma, Ipsen and Boiron.
You may also be interested in...
UK-based Alliance Pharma has strengthened its US offering by acquiring Biogix and its Amberen menopause supplement.
Ipsen CEO David Loew has kicked off a strategic review of the company's "non core" Consumer Healthcare business, which has endured a particularly tough year thanks to the COVID-19 pandemic.
UK consumer healthcare industry association PAGB is preparing its response to a "wide ranging" consultation on the future of how medical devices are regulated in the country. MHRA says it wants a system that streamlines product approvals while still prioritizing patient safety.